Septodont
- Company typePrivate
- Founded1932
- HeadquartersSaint-maur-des-fossés, France
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Septodont firmographics
Firmographics- Name
- Septodont
- Legal name
- SEPTODONT HOLDING
- Website
- https://septodontcorp.com
- Company type
- Private
- Founded year
- 1932
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Ownership category
- akta.pro rank
Septodont industry classification
Industry- Product category
- Dental Pharmaceuticals
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Dental Equipment and Supplies Manufacturing (339114)
- SIC
- Pharmaceutical Preparations (2834), Dental Equipment & Supplies (3843)
- akta.pro primary industry
- Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
- akta.pro secondary industry
- Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH)
Keywords
Where Septodont is headquartered
LocationHeadquarters
- HQ city
- Saint-maur-des-fossés
- HQ country
- France
- HQ region
- Europe
Offices7 records
Markets served
Septodont business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Infrastructure, Marketing or Sales
Revenue model
- Dental pharmaceutical products: Manufacturing and distribution of injectable and topical anesthetics, dental needles, anesthetic reversers, safety devices, syringes, and dental therapeutic products globally through direct sales and distribution partners.
- CDMO pharmaceutical manufacturing services: Contract development and manufacturing services through Novocol Pharma, specializing in aseptic injectable filling and combined medical device assembly. Services include pharmaceutical filling, combined product assembly, drug development and analytical services, and drug delivery system design.
- Biomaterials and endodontic products: Sale of proprietary bioactive materials including Biodentine™ products and BioRoot™ sealers for dental restoration and endodontic procedures.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
Septodont product offering
Product offeringCore offering
Septodont develops, manufactures, and globally distributes pharmaceutical dental products centered on injectable local anesthetics (Septocaine/articaine), endodontic and restorative biomaterials (Biodentine™, BioRoot™ RCS/Flow based on proprietary Active BioSilicate Technology), dental needles, safety syringes, anesthetic reversers, and buffers. Through its Novocol Pharma division, the company also offers pharmaceutical Contract Development and Manufacturing Organization (CDMO) services, including aseptic injectable filling and combination product assembly for pharmaceutical and biotech partners such as Moderna.
Product overview
Septodont is a world leader in the development, manufacturing, and distribution of innovative dental products, operating both as a premium dental product manufacturer and as a pharmaceutical Contract Development and Manufacturing Organization (CDMO). Its portfolio centers on pain management (injectable and topical anesthetics such as Septocaine/Articaine, Oraverse, safety syringes, dental needles) and bioactive restorative solutions powered by its proprietary Active BioSilicate (ABS) Technology™ (Biodentine™, Biodentine™ XP, BioRoot™ RCS, BioRoot™ Flow). The company also manufactures buffers, synthetic membranes, and distributes acquired brands including Cook-Waite (US anesthetics) and Inibsa (dental pharmaceuticals). Its Novocol Pharma division serves as a global injectable CDMO.
Differentiator
Problem solved
Functional benefit
Brands
- TDV: Restoration accessories manufacturer based in Brazil
- DLA Pharma
- Novocol Pharma
- Biodentine
- BioRoot
- Cook-Waite
- Septocaine
- Oraverse
Products and services
- Septocaine (Articaine) Injectable articaine-based local dental anesthetic produced by Septodont, the world's largest individual manufacturer of articaine-based injectables, used by dental practitioners for pain management during procedures.
- Biodentine™ Bioactive dentin substitute and pulp therapeutic material, the first all-in-one product capable of entirely replacing dentin in both crown and root. Built on Septodont's proprietary Active BioSilicate (ABS) Technology™ platform, it has helped save 5 million teeth worldwide.
- Biodentine™ XP Advanced dentin substitute delivering the therapeutic benefits of Biodentine™ in a pre-dosed, ready-to-mix capsule format used with a mixer and dispensing gun, ideal for the Bio-Bulk Fill procedure for filling deep carious lesions in a single visit.
- BioRoot™ RCS Bioceramic root canal sealer based on tricalcium silicate technology that revolutionized cold obturation techniques, used in endodontic procedures by dental practitioners.
- BioRoot™ Flow Next-generation bioactive root canal sealer presented in a ready-to-use syringe, offering excellent clinical outcomes in both cold and warm obturation techniques with powerful adhesion and an outstanding hermetic seal.
- Oraverse The first local anesthesia reversal agent, acquired in 2011, enabling faster return to normal sensation and function after dental procedures for dental practitioners and their patients.
- Ultra Safety Plus Twist Safety syringe system designed to reduce needlestick injuries during dental procedures, providing dental practitioners with improved injection safety.
- Buffer Pro Innovative solution launched in 2025 for buffering local anesthetics before injection, designed to reduce injection discomfort and improve anesthetic effectiveness for dental practitioners.
- R.T.R.+ Membrane Synthetic membrane used in dental surgical procedures such as guided bone regeneration, for dental practitioners performing implantology and periodontal surgery.
- Dental Needles Dental needles manufactured at Septodont's dedicated SOFIC production site in France, sold to dental practitioners and clinics globally as a core ancillary to anesthetic delivery.
- Active BioSilicate (ABS) Technology™ Proprietary patented technology platform based on ultra-pure tricalcium silicate, developed over 10+ years of research and clinical collaboration, underpinning products such as Biodentine™ and BioRoot™ RCS. Protected by 120+ patents in 100+ countries.
- Novocol Pharma CDMO Services Contract Development and Manufacturing Organization services within Septodont, specializing in high-volume aseptic filling of injectable cartridges and combination product assembly. Serves pharmaceutical and biotech customers globally, including as Canada's partner with Moderna for filling and finishing respiratory mRNA vaccines.
- Cook-Waite Dental anesthetic brand serving the U.S. market, acquired by Septodont in 2017.
Quantifiable outcome
- 5 million teeth saved through Biodentine™ dentin restoration materials
- +3 more outcomes
Companies that use Septodont
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Septodont technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Septodont partnerships and signals
Strategic signalPartnerships
23 partnerships are on record, tiered core and minor.
- DentroidcoreGlobal development and commercialization partnership to advance Dentroid's Nuralyte® technology using controlled light energy for largely needle-free pain management in common dental procedures. Combines Septodont's market leadership (30 anesthetic cartridges injected worldwide every second) with Dentroid's photonics-based platform to develop non-invasive dental pain solutions.
- Micro-MegacoreStrategic distribution partnership announced for endodontic products, combining Septodont's product portfolio with Micro-Mega's distribution capabilities.
- InibsacoreSeptodont acquired a controlling stake in Inibsa, a global dental healthcare company based in Barcelona, Spain. Transaction aims to accelerate Inibsa's growth domestically in Iberia and globally, expanding Septodont's presence in the Spanish and Portuguese dental pharmaceutical markets.
- SanofiminorAcquisition of Sanofi's 4 dental product portfolio, expanding Septodont's product offerings.
- Novocol Pharma (Moderna)coreNovocol Pharma serves as Canada's partner with Moderna for the filling and finish of respiratory mRNA vaccines, demonstrating CDMO capabilities in aseptic pharmaceutical manufacturing.
- Immersify EducationminorEducational partnership providing interactive dental education platform with 3D simulated clinical cases, quizzes, and games covering topics like local anesthetic administration, pain management, dentin restoration, and Biodentine™ usage.
- World Health OrganizationminorPartnership with international health bodies like WHO to renovate dental care centers and provide oral disease prevention training in Madagascar, Laos, and other underserved populations.
- Endodontic Aid International (AOI)minorPartnership to improve percutaneous procedures in Laos and Madagascar, supporting healthcare safety in developing countries.
- SimplonminorPartnership supporting digital skills training and professional pathways, helping launch Social Digital School in Val-de-Marne with 100 trainees gaining qualifications.
- America's ToothFairyminorPartnership delivering preventative and restorative dental care, oral hygiene products, and education to underserved children in the US. Reached 2.9 million children since 2008.
- RoseUp AssociationminorPartnership supporting women affected by cancer in France, providing financial assistance for classes, workshops, and events free of charge. Supported 426 women in 2022.
- Handicap InternationalminorSupport for displaced people and humanitarian aid in Ukraine war, including emergency prosthetic limbs, wheelchairs, and psychosocial treatment.
- The Safe AssociationminorPartnership providing medical supplies and logistics support for Ukraine, including use of Croissy-Beaubourg warehouse when their logistics arrangements collapsed.
- Bus Social DentaireminorSolidarity dental buses equipped with dental care trays and volunteer dentists traveling to vulnerable communities in six European countries to provide free dental care.
- Order of MaltaminorPartnership providing meals for 800 displaced children during Ukraine war, supporting their health, wellbeing, and education.
- Emmaüs SolidaritéminorSupport for Ukrainian refugees' integration through French language skills and employment support in Val-de-Marne.
- Cop1 Solidarités EtudiantesminorFunding for refrigerated van rental to distribute chilled produce to students in need in Paris, with connected oral care services.
- Louvre MuseumminorProud patron supporting cultural heritage preservation, including development of la Chaire du Louvre lecture series and acquisition of cultural treasures.
- French National Library (BNF)minorSupport for purchasing culturally important works of art, hosting literary lectures, and compiling provenance file with almost 300,000 records over 35 years.
- Science Based Targets initiative (SBTi)minorPreparing near-term company-wide emissions-reduction target with SBTi including complementary Scope 3 target.
- Office National des Forêts (ONF)minorThree-year agreement to plant 15,000 trees per year to restore ecosystems and support long-term forest preservation.
- Fondation de France and AnyamaminorPartnership for sustainable forest management in 2024.
- 30+ academic universitiesminorAcademic partnerships with prestigious universities worldwide providing access to products, facilities, and funding for research collaborations and evidence-based practice development.
Scale indicators17 records
Recent moves2 records
Expansion highlights8 records
Septodont competitors and assessment
Company assessmentBroad incumbents
- Dentsply Sirona: Dentsply Sirona is the world's largest diversified dental equipment and consumables manufacturer, with a portfolio spanning endodontic files (where Septodont competes via BioRoot and Micro-Mega partnership), imaging, CAD/CAM, and orthodontics. It is a broad incumbent in the same dental practitioner customer base that Septodont serves, with overlapping endodontic and consumables categories.
- 3M Oral Care: 3M's Oral Care division offers dental restoratives, preventive products, and orthodontic solutions—overlapping with Septodont's Biodentine line, dental needles (Septodont's SOFIC), and broader dental practitioner channel. As a broad incumbent in dental consumables, 3M competes for the same dental professional wallet share.
- Colgate-Palmolive (Professional Oral Health): Colgate-Palmolive's professional oral health division sells preventive and restorative products to dental professionals globally. As a broad incumbent with established dental practitioner relationships, it competes for share-of-wallet with Septodont's restorative and endodontic portfolio.
- Envista Holdings: Envista is a dental equipment and consumables platform (Nobel Biocare, Ormco, KaVo Kerr) that competes with Septodont across endodontic and restorative consumables. As a broad dental incumbent, it serves the same dental practitioner base and overlaps with Septodont's endodontic product line.
Regional players
- Henry Schein: Henry Schein is a leading dental supply distributor serving ~80% of US dental practices, distributing products from many manufacturers including dental anesthetic and endodontic brands. While not a direct product competitor, it is a major channel partner for dental practitioners globally—the same target customer Septodont serves with its branded portfolio.
- Patterson Companies: Patterson Companies is a US-focused dental and animal health supply distributor, serving dental practitioners across North America. It represents both a competitive threat (as a channel that could disintermediate) and a peer in serving the same end-dentist customer base with related consumables and equipment.
Direct peers
- Catalent: Catalent is a global CDMO specializing in softgel, oral dose, sterile injectable, and biologic fill-finish services. It directly competes with Septodont's Novocol Pharma division for aseptic injectable fill-finish contracts, including in the mRNA/biologics space where both serve top-tier pharma partners.
- Lonza: Lonza is the world's largest CDMO offering mammalian biologics, small molecules, and cell/gene therapy services with extensive aseptic fill-finish capacity. It directly competes with Novocol Pharma in sterile injectable manufacturing, particularly for high-value biologic and mRNA contracts.
- Recipharm: Recipharm (part of EQT/CD&R-owned arm) is a major European CDMO specializing in sterile injectables, blow-fill-seal, and small molecule manufacturing. It competes directly with Novocol Pharma for sterile injectable contract manufacturing in European and global markets.
Emerging players
- Align Technology: Align Technology (Invisalign) operates in the orthodontic clear aligner segment and increasingly intersects with dental practices through digital workflows. While its core product is different, Align is a credible adjacent peer in the dental practitioner value chain where Septodont's anesthetic and restorative products are also consumed.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Septodont social profiles
Digital presenceSeptodont compliance and trust
Trust signalCompliance4 records
Septodont financial estimates
Financial estimateRevenue estimate
Valuation estimate
Septodont leadership team
Management profileNumber of profiles
Profiles15 records
Septodont subsidiaries and ownership
Company hierarchySubsidiaries8 records
Septodont funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Septodont M&A and investment
M&A and investmentM&A2 records
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Septodont
What does Septodont do?
Septodont develops, manufactures, and globally distributes pharmaceutical dental products centered on injectable local anesthetics (Septocaine/articaine), endodontic and restorative biomaterials (Biodentine™, BioRoot™ RCS/Flow based on proprietary Active BioSilicate Technology), dental needles, safety syringes, anesthetic reversers, and buffers. Through its Novocol Pharma division, the company also offers pharmaceutical Contract Development and Manufacturing Organization (CDMO) services, including aseptic injectable filling and combination product assembly for pharmaceutical and biotech partners such as Moderna.
Is Septodont a public or private company?
Septodont is a private company. It is classified as family owned and is currently operating.
When was Septodont founded?
Septodont was founded in 1932. It employs 501 to 1,000 people.
Where is Septodont based?
Septodont is headquartered in Saint-maur-des-fossés, France, in the Europe region.
How does Septodont make money?
Three revenue lines are on record. Dental pharmaceutical products are the primary driver. The others are CDMO pharmaceutical manufacturing services and biomaterials and endodontic products.
Who are Septodont's main competitors?
Broad incumbents on record are Dentsply Sirona, 3M Oral Care, Colgate-Palmolive (Professional Oral Health) and Envista Holdings. Regional players are Henry Schein and Patterson Companies. Direct peers are Catalent, Lonza and Recipharm. Align Technology is listed as an emerging player.
Does Septodont have an API?
No public API is recorded for Septodont.
What industry is Septodont in?
Septodont's product category is Dental Pharmaceuticals. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGABAH, Sterile Fill-Finish & Aseptic Manufacturing CDMO. Its NAICS code is 3254 and its SIC code is 2834.